SA-mRNA influenza vaccine (Seqirus/CSL)

N/A

Report date: 2025/12/12 17:31:38

Base Information

Drug NameSA-mRNA influenza vaccine (Seqirus/CSL)

Drug Alias NameSA-mRNA seasonal influenza vaccine (CSL)SAM vaccine (CSL)SAM vaccine (Seqirus)self-amplifying messenger RNA vaccine (Seqirus)self-amplifying messenger RNA vaccine (CSL) +[6]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine > self-amplifying mRNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCsl Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCsl Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A